Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision v3.4.2 and removed references to v3.4.1 and the government funding status notice; core study content and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a Show glossary option and new labels No FEAR Act Data and Revision: v3.4.0, and updated the QC label to Last Update Submitted that Met QC Criteria. Removed the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

- Check35 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now features a Locations section listing Kansas as a site, and the revision updated to v3.3.3; the old Kansas Locations section and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1, a minor update in the footer that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.